Filing Details
- Accession Number:
- 0001127602-17-026989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-05 18:31:37
- Reporting Period:
- 2017-08-31
- Accepted Time:
- 2017-09-05 17:31:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387521 | R James Meyers | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp Worldwide Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-31 | 60,000 | $21.00 | 62,715 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-31 | 43,300 | $83.01 | 19,415 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-31 | 16,700 | $83.64 | 2,715 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-08-31 | 60,000 | $0.00 | 60,000 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-10-22 | No | 4 | M | Direct |
Footnotes
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $82.50 to $83.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $83.51 to $83.91. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
